Skip to main content
Premium Trial:

Request an Annual Quote

Genentech Gains Rights to Gene Found by Human Genome Sciences

NEW YORK, Aug. 8 (GenomeWeb News) - Genentech has acquired worldwide patent rights to develop and market drugs using a gene found by Rockville, Md.-based Human Genome Sciences, the companies announced yesterday.

 

Under the terms of the agreement, Genentech has exclusive rights to use the gene to develop any drug for the treatment of immunological or neurological diseases, or cancer. It has non-exclusive rights to develop and commercialize small molecules.

 

Genentech will pay Human Genome Sciences, which lost $47 million last quarter, royalties and milestone payments for any drugs developed.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.